Matches in Nanopublications for { <http://purl.org/np/RAsqd9h62vEr9LmPDdCJGAccvaZ50fOhW1ZO-w1CyKSDY#association> ?p ?o ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- association type Statement assertion.
- association label "venclexta is a bcl 2 inhibitor indicated for the treatment of adult patients with chronic lymphocytic leukemia cll or small lymphocytic lymphoma sll 1 1 in combination with azacitidine or decitabine or low dose cytarabine for the treatment of newly diagnosed acute myeloid leukemia aml in adults who are age 75 years or older or who have comorbidities that preclude use of intensive induction chemotherapy 1 2 venclexta is indicated for the treatment of adult patients with chronic lymphocytic leukemia cll or small lymphocytic lymphoma sll venclexta is indicated in combination with azacitidine or decitabine or low dose cytarabine for the treatment of newly diagnosed acute myeloid leukemia aml in adults who are age 75 years or older or who have comorbidities that preclude use of intensive induction chemotherapy this indication is approved under accelerated approval based on response rates see clinical studies 14 2" assertion.
- association object DOID_1040 assertion.
- association predicate treats assertion.
- association subject drugbank:DB11581 assertion.
- association relation TreatmentIndication assertion.
- association provided_by NeuroDKG assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.